Literature DB >> 18484420

Maternal serum Chlamydia pneumoniae antibodies and CRP levels in women with preeclampsia and gestational hypertension.

Liisa Karinen1, Maija Leinonen, Aini Bloigu, Mika Paldanius, Pentti Koskela, Pekka Saikku, Anna-Liisa Hartikainen, Marjo-Riitta Jarvelin, Anneli Pouta.   

Abstract

OBJECTIVE: To determine whether Chlamydia pneumoniae antibodies and highly sensitive C-reactive protein (hsCRP) levels in maternal sera are associated with preeclampsia or gestational hypertension.
METHODS: C. pneumoniae antibodies and hsCRP levels were measured in maternal serum during first trimester (mean, 10.4 weeks of gestation) using the microimmunofluorescence (MIF) test and a highly sensitive immunoenzymometric assay, respectively.
RESULTS: No differences in the IgG antibody levels against C. pneumoniae or hsCRP levels were seen between the women with preeclampsia or gestational hypertension and those in the reference group. However, the women with preeclampsia and preterm delivery had serum IgG antibodies to C. pneumoniae (IgG titre > or =32) significantly more often in their first trimester sera compared with women having preeclampsia and full-term deliveries (p = 0.03). In addition, the proportion of subjects with C. pneumoniae IgG antibodies (IgG titre > or =32) and/or elevated CRP levels (> or =3.8 mg/L, upper quartile) was double among the women with preeclampsia and elective preterm delivery compared with the women with preeclampsia who delivered at term (p = 0.01).
CONCLUSION: Our results suggest that chronic C. pneumoniae infection and systemic low-grade inflammation may be associated with preeclampsia requiring elective delivery before 37 weeks gestation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18484420     DOI: 10.1080/10641950701885188

Source DB:  PubMed          Journal:  Hypertens Pregnancy        ISSN: 1064-1955            Impact factor:   2.108


  5 in total

1.  Low-Dose Aspirin May Prevent Trophoblast Dysfunction in Women With Chlamydia Pneumoniae Infection.

Authors:  Luis M Gomez; Lauren Anton; Shindu K Srinivas; Michal A Elovitz; Samuel Parry
Journal:  Reprod Sci       Date:  2018-12-20       Impact factor: 3.060

2.  Prenatal Chlamydia trachomatis infection increases the risk of preeclampsia.

Authors:  Catherine L Haggerty; Mark A Klebanoff; Inge Panum; Soren A Uldum; Debra C Bass; Jorn Olsen; James M Roberts; Roberta B Ness
Journal:  Pregnancy Hypertens       Date:  2013-07-01       Impact factor: 2.899

Review 3.  Human infectious diseases and risk of preeclampsia: an updated review of the literature.

Authors:  Malihe Nourollahpour Shiadeh; Zahra Behboodi Moghadam; Ishag Adam; Vafa Saber; Maryam Bagheri; Ali Rostami
Journal:  Infection       Date:  2017-06-02       Impact factor: 3.553

4.  Gestational Antibodies to C. pneumoniae, H. pylori and CMV in Women with Preeclampsia and in Matched Controls.

Authors:  Abdul Wajid; David Todem; Mark R Schleiss; David F Colombo; Nigel S Paneth
Journal:  Matern Child Health J       Date:  2022-08-06

5.  Trophoblast infection with Chlamydia pneumoniae and adverse pregnancy outcomes associated with placental dysfunction.

Authors:  Luis M Gomez; Samuel Parry
Journal:  Am J Obstet Gynecol       Date:  2009-05       Impact factor: 8.661

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.